Comparison of Bromcresol Green and Agarose Protein Electrophoresis for Quantitation of Serum Albumin in Multiple Myeloma
Author(s) -
Christine L.H. Snozek,
Amy K. Saenger,
Philip R. Greipp,
Sandra C. Bryant,
Robert A. Kyle,
S. Vincent Rajkumar,
Jerry A. Katzmann
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.088252
Subject(s) - nephelometry , albumin , multiple myeloma , serum protein electrophoresis , agarose , medicine , immunoelectrophoresis , turbidimetry , serum albumin , antibody , chromatography , chemistry , monoclonal , microbiology and biotechnology , immunology , monoclonal antibody , biology
The International Staging System for multiple myeloma has increased the importance of accurate measurement of serum albumin. Two common albumin assays, bromcresol green (BCG) and agarose gel protein electrophoresis (PEL), frequently yield discordant results, creating confusion regarding which assay is superior for use in myeloma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom